ISPOR Health Science Policy Council
2015 - 2017 Chair:
Scott D. Ramsey, MD, PhD
Member, Fred Hutchinson Cancer Research Center and
Professor, Schools of Pharmacy and Medicine
University of Washington, Seattle, WA, USA
ISPOR is an international scientific and educational nonprofit organization globally recognized as the authority for outcomes research and its use in health care decisions towards improved health. To ensure that ISPOR is addressing key research issues in outcomes research, the ISPOR Health Science Policy Council was established as an advisory council to the Board of Directors in 2004.
ISPOR provides a forum to facilitate the interchange of scientific knowledge in clinical, economic and patient outcomes. This knowledge is disseminated in ISPOR publications and meetings.
ISPOR Good Practice Task Force Reports have become ISPOR’s most important ‘products’ in terms of guidance in the areas of economic modeling, retrospective database analyses, prospective trial-based analyses, comparative effectiveness methods, preference-based methods, and patient-reported outcomes methods studies. These reports, published in Value in Health, are used by members, industry, academia, research, health technology assessors, patients and the public. ISPOR Good Practices for Outcomes Research reports are downloaded approximately 8,000 times per month.
The goal of the Council is to review and evaluate Good Practice Task Force proposals submitted by ISPOR members. The HSPC recommends proposals to ISPOR Board of Directors for discussion and further action.
The ISPOR Health Science Policy Council membership is composed of past ISPOR Presidents, recipients of the ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Award and key thought leaders in research selected by the Council.
To ensure the Council reflects the interests of the ISPOR membership, the Council and the Board of Directors can invite key scientific thought leaders from areas that are under-represented on the Council (e.g. patient-reported outcomes, preference/utility assessments, health care policy analysis and use of “real world” data, health care decision makers, etc.). The Council can also invite outcomes research experts to serve on an ad-hoc, as-needed basis.
Update on Comparative Effectiveness and Health Information Technology Legislation and Policy Developments, and Their Impact on Pharmacoeconomics
May 2009: ISPOR 14th Annual International Meeting Forum Presentation, Orlando, FL, USA